Navigation Links
Intercell AG Appoints Staph Leavenworth Bakali as Chief Business Officer
Date:9/30/2010

VIENNA, Sept. 30 /PRNewswire/ -- Intercell AG (VSE: ICLL) today announced that effective October 1, 2010, Staph Leavenworth Bakali will join its Management Board as Chief Business Officer with key responsibilities for the commercial aspects of the Company, directly leading Marketing and Sales, Corporate and Business Development, and Alliance Management. Staph will also play a key role with the other Management Board members in helping drive forward the Company's strategy. Prior to the appointment to Intercell AG's Management Board, Staph had stepped down from his position as member of the Supervisory Board of the company.

"Staph has an outstanding track record in the vaccines industry and has made major contributions to the success of some key vaccines businesses globally. His commercial and strategic experience ideally complement the skills of our current Management Board," said Gerd Zettlmeissl, Chief Executive Officer of Intercell AG. "We are proud to have Staph working with us towards the next growth phase of our Company."

"Having been a member of Intercell's Supervisory Board for almost five years, I have been impressed with the progress and capabilities of the Company and its people in creating value through innovation, industrialization and commercialization," said Staph Bakali. "I am delighted to join a very dynamic team and look forward to helping develop the business further."

Staph brings 20 years of vaccine industry experience from his previous leadership positions. He was recently Chief Executive Officer of Genocea Biosciences, a Boston (U.S.) based innovative biotech vaccine company, and previously Chief Operating Officer for ID Biomedical (Vancouver, Canada) and PowderJect (Oxford, UK), which were acquired by GlaxoSmithKline and Chiron, respectively. Staph Bakali was also previously head of Sales and Marketing for Chiron's global vaccine business and SmithKline Beecham's Vaccine Business Unit in France. Staph holds a Masters d
'/>"/>

SOURCE Intercell AG
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Intercell Acquires Antibody Technology Platform to Further Exploit Its Capabilities to Combat Infectious Diseases
2. Intercell AG Announces First Subject Enrolled in a Phase II Trial for the Further Development of Its Investigational Vaccine Enhancement Patch to Improve Pandemic Influenza Prevention in Collaboration With U.S. Department of Health and Human Services (HHS
3. Intercell Starts a Phase I Clinical Trial for a New Streptococcus pneumoniae Vaccine
4. Intercell AG Partners with Inclinix to Enroll 1800 Volunteers for Phase III Travelers Diarrhea Vaccine Study
5. USD 12.5 m Funding for the Development of Intercells Vaccine Patch System for Pandemic Influenza From U.S. Department of Health and Human Services (HHS)
6. Favourable Six Months Follow-Up Results From Intercells Phase II Therapeutic Hepatitis C Program
7. Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection
8. Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation
9. 3-V Biosciences Appoints Merdad V. Parsey, MD, PhD, as Chief Executive Officer
10. Tigris Pharmaceuticals Appoints Neil Flanzraich to Executive Chairman of the Board
11. Laureate Pharma Appoints Steven R. Johnson as Vice President, Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... DIEGO , May 20, 2013  Volcano Corporation ... manufacturer of precision guided therapy tools designed to enhance ... disease, today announced it will highlight its efforts to ... its Fractional Flow Reserve (FFR) and iFR ® ... and educational presentations and events at EuroPCR 2013 in ...
(Date:5/20/2013)... , May 20, 2013 The Board ... subsidiary companies include OMNIlife science®, Inc., Enztec, Ltd., and ... their Board.  Guy Mayer , ... Chairman of the Board of Directors and David Johnson, ... a director. Before joining OSI as ...
(Date:5/20/2013)... , May 20, 2013  Upsher-Smith Laboratories, ... development of new treatments for diseases of the ... its newly designed website, upsher-smith.com . The ... narratives.  As part of the company,s mission statement ... branding campaign centers around people with a story ...
Breaking Medicine Technology:Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 2Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 3Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 4Orthopaedic Synergy, Inc. Announces Key Additions to the Board of Directors 2Orthopaedic Synergy, Inc. Announces Key Additions to the Board of Directors 3Upsher-Smith Introduces Newly Redesigned Corporate Website 2
... , WALTHAM, Mass., Dec. ... research and advisory firms for pharmaceutical and healthcare issues, ... metastatic colorectal cancer treatment, Roche/Chugai,s Avastin will face increasing ... France and Spain. , The new Special European Physician ...
... Genoptix, Inc. (Nasdaq: GXDX ), a specialized laboratory ... Bank 2009 MedTools Investor Conference to be held at the ... , Genoptix,s EVP and COO, Sam Riccitelli, will be ... 2009. He will provide an overview of the Company,s ...
Cached Medicine Technology:For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 2For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 3Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference 2
(Date:5/21/2013)... (PRWEB) May 21, 2013 The Michigan ... meeting in Lapeer on , June 11th. , Meeting ... Location: Lapeer Regional Medical Center,     Conference Room 5 (Lower ... These meetings are designed to assist people with lupus ... one another, and to get a better understanding of ...
(Date:5/21/2013)... According to the Center for Disease Control and ... year. Over 800,000 of these bites require medical attention, ... should be aware of the danger that dog bites pose ... and children may sustain more serious injuries than an adult. ... the ages of 5 and 9 are at the greatest ...
(Date:5/20/2013)... Heritage Woods of Gurnee , a BMA ... hosting Breakfast and Bingo at 8:30 a.m. on Friday, ... 3775 Grand Ave. in Gurnee, Illinois, serves older adults ... some help to maintain their independence. , "Come and ... says Tammy Temaner-Rosas, Director of Marketing for Heritage Woods ...
(Date:5/20/2013)... May 20, 2013 When people ... not always to become a celebrity. New Jersey ... 2013 ABC News report (“Chris Christie Says Lap ... clear that the surgery was not done so ... gain celebrity status as a former lap band ...
(Date:5/20/2013)... 20, 2013 In order to prepare for ... wellness team from DrSmartphoneMD launched an article series to raise ... The series launched with the precautions that need ... the DrSmartphoneMD program are not one of the 3.5 million ... more than 90% of all skin cancer cases are associated ...
Breaking Medicine News(10 mins):Health News:Personal Injury Law Firm Announces New Informational Graphic Regarding Dog Bite Injuries 2Health News:Heritage Woods of Gurnee Affordable Assisted Living Community to Host Breakfast and Bingo 2Health News:The Lap Band Center: Dr. Atul Madan Applauds Chris Christie's Dedication to Family and Loss of 30 Pounds After Lap Band Surgery 2Health News:The Lap Band Center: Dr. Atul Madan Applauds Chris Christie's Dedication to Family and Loss of 30 Pounds After Lap Band Surgery 3Health News:Combat Skin Cancer In Summer Months 2
... , SAN FRANCISCO, Dec. 16 ... software and professional services solutions for the healthcare industry, ... division. Quantros has named software industry veteran Michael Tulloch, ... work from the company,s new Marlborough, MA office. , ...
... Boston University School of Medicine,s (BUSM) Pulmonary Center has ... Heart, Lung, and Blood Institute to derive stem cells ... Darrell Kotton, MD, associate professor of medicine and ... medicine, are the principal investigators of this new grant ...
... A ... impact on employee presenteeism and bottom line benefits. , ... Minneapolis, MN (PRWEB) December 16, 2009 -- A ... employee participation in health and wellness programs by implementing an incentive program. ...
... Two million screenings conducted through national AAD program ... from melanoma, the deadliest form of skin cancer, almost every ... That,s why thousands of dermatologists across the country offer free ... of Dermatology,s (AAD) National Melanoma/Skin Cancer Screening Program. The program ...
... ... the world,s largest online community for physicians, today announced the ... MD Social Media Conversations ." The report examines physician ... complete analysis of a variety of topics, including the therapies ...
... , , WILMINGTON, Delaware, December ... to outsource their accurate forecast models,for new and inmarket ... solutions to various players. These pharma,forecasting solutions are designed ... These have a substantial impact on pricing, launch, product ...
Cached Medicine News:Health News:Safety and Quality Software Developer Quantros, Inc. Launches Healthcare IT Consulting Division 2Health News:Boston University School of Medicine's pulmonary center receives $1.4 million grant 2Health News:Hallmark Insights' Employer Survey Reveals Cost-Savings Benefits of Health & Wellness Programs 2Health News:Dermatologists Reach Skin Cancer Screening Milestone 2Health News:Dermatologists Reach Skin Cancer Screening Milestone 3Health News:Sermo Vitals Report(TM) Quantifies One Year of Physician Conversation About Diabetes 2Health News:Sermo Vitals Report(TM) Quantifies One Year of Physician Conversation About Diabetes 3Health News:MarketsandMarket's Integrated Patient-based Forecasting Solution for Pharmaceutical Industry, Mainly for Pipeline Products 2Health News:MarketsandMarket's Integrated Patient-based Forecasting Solution for Pharmaceutical Industry, Mainly for Pipeline Products 3
... membrane parasite soluble lysate ... as antigen. Since this ... than the recombinant kit, ... use two ELISA techniques ...
The Cellabs T. cruzi IgG CELISA is a direct ELISA kit designed to detect antibodies produced during T. cruzi infections (Chagas disease)....
... The dual-electrode SPL defibrillator lead ... design, offering the flexibility and ... Designed for the physician who ... shocking coils, the SPL lead ...
... The Medtronic Subcutaneous Lead ... implanted subcutaneously with the use ... Model 6996T. Improved SQ design ... DFTs, a fast and easy ...
Medicine Products: